Pexmetinib
Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.
| Catalog Number | T6934 |
| Alternative Name(s) | ARRY-614 |
| Research Area | Tyrosine Kinase/Adaptors|||MAPK|||Autophagy |
| Molecular Formula | C31H33FN6O3 |
| CAS# | 945614-12-0 |
| Purity | 99.07% |
| SMILES | Cc1ccc(cc1)-n1nc(cc1NC(=O)NCc1cc(F)ccc1Oc1ccc2n(CCO)ncc2c1)C(C)(C)C |
| Size | 2 mg |
| Supplier Page | https://www.targetmol.com/compound/Pexmetinib |
| Additional Information | https://www.targetmol.com/datasheet/T6934 |